Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway

Suolin Zhang(Second Hospital of Shandong University), Yayan Wang(Yanbian University Hospital)
Oncology Letters
February 8, 2018
Cited by 37


Related Papers